Cargando…
Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group
Genetic testing for hereditary cancer predisposition has evolved rapidly in recent years with the discovery of new genes, but there is much debate over the clinical utility of testing genes for which there are currently limited data regarding the degree of associated cancer risk. To address the disc...
Autores principales: | Taylor, Amy, Brady, Angela F, Frayling, Ian M, Hanson, Helen, Tischkowitz, Marc, Turnbull, Clare, Side, Lucy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992364/ https://www.ncbi.nlm.nih.gov/pubmed/29661970 http://dx.doi.org/10.1136/jmedgenet-2017-105188 |
Ejemplares similares
-
Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations
por: Garrett, Alice, et al.
Publicado: (2021) -
UK recommendations for SDHA germline genetic testing and surveillance in clinical practice
por: Hanson, Helen, et al.
Publicado: (2023) -
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2
por: Hanson, Helen, et al.
Publicado: (2023) -
UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants
por: Hanson, Helen, et al.
Publicado: (2021) -
Consensus clinical management guidelines for Alström syndrome
por: Tahani, Natascia, et al.
Publicado: (2020)